MASH/MASLD | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

4,380 results for “MASH/MASLD”

Trials

View all 3701 →

Active, not recruiting

Korean Real-world Study on MASLD/MASH Outcomes.

10,000 participants · First posted Jul 31, 2026

Prognostic Factors for HCC and Liver Transplantation in Patients with MASLD/MASH

1,000 participants · First posted Feb 7, 2025

A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH

67 participants · First posted May 13, 2024

Drugs

View all 40 →

MASH(Repair)

oligonucleotide therapeutic (dyslipidemia/MASH/MAFLD)

MASL

Organizations

Mast Therapeutics, Inc.

United States

Mister Car Wash

United States

FONDAZIONE EDMUND MACH

Italy

News

View all 633 →

Sagimet Advances Denifanstat into Phase 3 Trials for MASH and MASLD Following FDA Feedback

MASH and MASLD Underdiagnosed in the US, True Prevalence Higher Than Claims Data Suggests

Resmetirom Shows Promise in Treating MASLD/MASH: A Comprehensive Review of Clinical Trials

Page 1 of 438